In vitro neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity
- PMID: 39246127
- DOI: 10.1080/17425255.2024.2401584
In vitro neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity
Abstract
Introduction: Chemotherapy induced peripheral neurotoxicity (CIPN) is a long-lasting, or even permanent, late toxicity caused by largely used anticancer drugs. CIPN affects a growing population of cancer survivors and diminishes their quality of life since there is no curative/preventive treatment. Among several reasons for this unmet clinical need, there is an incomplete knowledge on mechanisms leading to CIPN. Therefore, bench side research is still greatly needed: in vitro studies are pivotal to both evaluate neurotoxicity mechanisms and potential neuroprotection strategies.
Areas covered: Advantages and disadvantages of in vitro approaches are addressed with respect to their applicability to the CIPN field. Different cell cultures and techniques to assess neurotoxicity/neuroprotection are described. PubMed search-string: (chemotherapy-induced) AND (((neuropathy) OR neurotoxicity) OR neuropathic pain) AND (in vitro) AND (((((model) OR SH-SY5Y) OR PC12) OR iPSC) OR DRG neurons); (chemotherapy-induced) AND (((neuropathy) OR neurotoxicity) OR neuropathic pain) AND (model) AND (((neurite elongation) OR cell viability) OR morphology). No articles published before 1990 were selected.
Expert opinion: CIPN is an ideal experimental setting to test axonal damage and, in general, peripheral nervous system mechanisms of disease and neuroprotection. Therefore, starting from robust preclinical data in this field, potentially, relevant biological rationale can be transferred to other human spontaneous diseases of the peripheral nervous system.
Keywords: Neurotoxicity; anatomy; chemotherapy; in vitro testing; peripheral neuropathy; peripheral neurotoxicity.
Similar articles
-
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity.Int J Mol Sci. 2024 Jun 14;25(12):6552. doi: 10.3390/ijms25126552. Int J Mol Sci. 2024. PMID: 38928257 Free PMC article. Review.
-
Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms.Expert Rev Neurother. 2020 Oct;20(10):1005-1016. doi: 10.1080/14737175.2020.1796639. Epub 2020 Aug 6. Expert Rev Neurother. 2020. PMID: 32667212 Review.
-
Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.Cancer. 2018 Jun 1;124(11):2289-2298. doi: 10.1002/cncr.31248. Epub 2018 Feb 20. Cancer. 2018. PMID: 29461625 Free PMC article. Review.
-
Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue.J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S6-S12. doi: 10.1111/jns.12337. J Peripher Nerv Syst. 2019. PMID: 31647155 Review.
-
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).Support Care Cancer. 2017 Jan;25(1):195-204. doi: 10.1007/s00520-016-3404-y. Epub 2016 Sep 9. Support Care Cancer. 2017. PMID: 27612466 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical